What's Going On With NextCure Stock Wednesday? - NextCure (NASDAQ:NXTC)

NextCure ($NXTC) rises 2.1% premarket after presenting positive Phase 1 clinical data for ovarian cancer treatment SIM0505 at ASCO.

Raccontata dabenzinga.com